OTCMKTS:GENTY

Gentium Srl (GENTY) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
6,528 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
GENTY stock logo

About Gentium Srl Stock (OTCMKTS:GENTY)

Gentium SpA is a biopharmaceutical company focused on the development and manufacture of its product candidate, defibrotide, an investigational drug based on a mixture of single-stranded and double-stranded deoxyribonucleic acid (DNA) extracted from pig intestines. The Company’s development of defibrotide has been focused on the treatment and prevention of a disease called hepatic veno-occlusive disease ( VOD), a condition that occurs when veins in the liver are blocked as a result of cancer treatments, such as chemotherapy or radiation, that are administered prior to stem cell transplantation. In February 2014, Jazz Pharmaceuticals PLC acquired the 98% interest in Gentium SpA (Gentium).

GENTY Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive GENTY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gentium Srl and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
OTCMKTS:GENTY
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Khalid Islam Ph.D. (Age 61)
    Chairman of the Board, Chief Executive Officer, Interim Scientific Director
  • Salvatore Calabrese (Age 44)
    Chief Financial Officer, Chief Operating Officer
  • Carin Heringa (Age 52)
    Senior Vice President, Scientific Director
  • Marco Maria Brughera (Age 60)
    Director
  • Laura Ferro Ph.D. (Age 62)
    Director
  • Gigliola Bertoglio CPA (Age 79)
    Independent Director
  • Bobby W. Sandage Jr. (Age 63)
    Ph.D., Independent Director
  • Elmar J. Schnee (Age 57)
    Independent Director

GENTY Stock Analysis - Frequently Asked Questions

How do I buy shares of Gentium Srl?

Shares of GENTY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:GENTY) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners